Partial characterization of a cell motility factor from human urine

Area of Science:

• Biochemistry
• Oncology
• Cell Biology

Background:

• Bladder cancer diagnosis relies on invasive procedures.
• Novel, non-invasive biomarkers are needed for early detection.
• Urine analysis offers a promising avenue for biomarker discovery.

Purpose of the Study:

• To investigate the presence and characteristics of a motility-stimulating factor in the urine of bladder cancer patients.
• To evaluate the potential of this factor as a diagnostic marker for bladder carcinoma.

Main Methods:

• Urine samples from 21 patients (bladder cancer history or gross tumor) were dialyzed and concentrated.
• BALB/c/3T3 cells were used to assess cell motility activity.
• Protease treatment, heat inactivation, and high-performance liquid chromatography (HPLC) were employed for characterization.

Main Results:

• Urine from patients with gross bladder tumors showed significantly higher cell migration activity (167% +/- 14) compared to those with a history of bladder cancer (64% +/- 19).
• Protease treatment and heating (100°C for 2 min) reduced activity by 95% and 86%, respectively.
• HPLC analysis identified the highest activity in fractions with a molecular weight between 18,000 and 30,000.

Conclusions:

• A motility-stimulating factor is present in the urine of bladder cancer patients.
• This factor's activity is significantly elevated in patients with gross tumors.
• The characterized properties suggest this factor could be a potential non-invasive biomarker for detecting bladder carcinoma.